IMR Press / CEOG / Volume 49 / Issue 9 / DOI: 10.31083/j.ceog4909210
Open Access Editorial
Present and Future Perspectives of Urogynecology
Show Less
1 Department of Obstetrics & Neonatology; and Istituto di Ricovero e Cura a Carattere Clinico Scientifico (IRCCS), AUSL di Reggio Emilia, 42122 Reggio Emilia, Italy
2 Department of Obstetrics & Gynecology, “Franchini” Hospital, Montecchio Emilia, Azienda Unità Sanitaria Locale di Reggio Emilia, 42122 Reggio Emilia, Italy
*Correspondence: Gabriele.Tonni@ausl.re.it (Gabriele Tonni)
Academic Editor: Michael H. Dahan
Clin. Exp. Obstet. Gynecol. 2022, 49(9), 210; https://doi.org/10.31083/j.ceog4909210
Submitted: 10 March 2022 | Revised: 25 July 2022 | Accepted: 29 July 2022 | Published: 7 September 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

In recent years, increasing attention has been focused on health prevention, correct diet and lifestyle to ensure a state of well-being. As physicians, we are daily witnesses to how embarrassing it is for patients to refer common health problems such as overactive bladder (OAB)/incontinence or pelvic organ prolapse [1].

Although overactive bladder incontinence and pelvic organ prolapse are normal consequences of the aging process, the role of the discipline called Urogynecology needs to be further highlighted.

Urogynecology is a synchratic neologism between “urology” and “gynecology” used to define this specific field that deals with pathological conditions affecting the female lower urinary tract. Recurrent and relapse of cystitis, uro-genital prolapses, and overactive bladder incontinence are frequent disfunctions affecting the quality of life of women, especially in their elderly years.

The impressive progresses made over the last 20 years both in pathophysiology investigations and in the development of novel surgical approaches have resulted in an enhanced treatment rate, thanks to minimally invasive surgical access that is chracterized by an extremely short hospitalization time and maximum patient satisfaction. In addition, Urogynecology has been progressively and appropriately combined with proctology and physiotherapy to ensure the best clinical diagnosis and the best gold standard of care by the multispecialist team.

Urogynecology should rely upon a thorough diagnosis of pelvic-perineal dysfunctions and related imaging techniques, and assigned according to international classifications such as that using the POP-Q system [2].

Even the diagnosis concerning the so-called “posterior compartment”, considered to be a borderline field up until a few years ago, today is considered as part of this new multidisciplinary concept, resulting in increased patient satisfaction.

Actually, for overactive bladder incontinence, the surgical approaches considered to be the gold standard of care are the Trans Obturator Tape (TOT) or the transurethral injection of bulking agents, which are performed in a one-day-surgery setting or at an outpatient clinic [3, 4, 5].

On the other side, surgical treatments for urogenital prolapse can be performed vaginally or using either conventional laparoscopy or robotic surgery, where available at the local site. The latter technique is specifically indicated when urogenital prolapse is associated with apical compartment prolapse. Notewithstanding, key-hole surgery has the advantage of short hospital stays, usually in the range of two or three days [6, 7, 8, 9, 10].

However, we must not forget the importance of behavioral and rehabilitation therapy, nor that of oral medications or intravesical therapy such as Botulinum toxin injection for the treatment of overactive bladder incontinence [5].

As previously mentioned, the role of Urogynecology has long remained almost unrecognized: the time has come for this discipline to be considered an emerging multidisciplinary field of application, and specialists worldwide should be called upon to create an international forum of experts, in order to share data and release standardized recommendations and guidelines.

As Guest Editors, our aim and wish is to stimulate a collaborative network and discussion between the physicians involved, sharing their clinical experiences and thus contributing to the development of a more patient-centered medicine.

Author Contributions

GT, DV and EB all contribute to the drafting and revision of the manuscript. All authors read and approved the final manuscript.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Authors would like to aknowledge Isituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Azienda Unità Sanitaria Locale di Reggio Emilia, 42122 Reggio Emilia, Italy for valuable scientific contribution.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest. GT is serving as one of the Editorial Board members and Guest editors of this journal. DV and EB are serving as Guest editors of this journal. We declare that GT, DV and EB had no involvement in the peer review of this article and have no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to MHD.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References
[1]
Hsiao S, Lin H. Impact of the mid-urethral sling for stress urinary incontinence on female sexual function and their partners’ sexual activity. Taiwanese Journal of Obstetrics and Gynecology. 2018; 57: 853–857.
[2]
Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging. The Journal of Medicine and Life. 2011; 4: 75–81.
[3]
Huang WC, Yang JM, Chen HF. Five-year clinical and imaging outcomes of primary transobturator midurethral sling procedures for uncomplicated urodynamic stress incontinence. Maturitas. 2020; 138: 42–50.
[4]
Natale F, Illiano E, La Penna C, Balsamo R, Costantini E. Mixed urinary incontinence: a prospective study on the effect of trans-obturator mid-urethral sling. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2018; 221: 64–69.
[5]
Hajebrahimi S, Shamsi-Sisi H, Jahantabi E, Salehi-Pourmehr H, Hashim H. Efficacy of combination therapy of mid-urethral sling and low-dose Abobotulinumtoxin-A injection in mixed urinary incontinence. Neurourology and Urodynamics. 2022; 41: 211–219.
[6]
Campagna G, Vacca L, Panico G, Caramazza D, Lombisani A, Scambia G, et al. Laparoscopic lateral suspension for pelvic organ prolapse: a systematic literature review. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2021; 264: 318–329.
[7]
Davila HH, Deshommes H, Paul A, Abdelhameed S, Filippi C, Bello L, et al. Evaluation of the Pubocervical Fascia with 3-Dimensional Endovaginal Ultrasonography and Correlation with Intraoperative Findings during Robotic Sacrocervicopexy. Urology. 2021; 158: 81–87.
[8]
Pushkar DY, Kasyan GR, Popov AA. Robotic sacrocolpopexy in pelvic organ prolapse: a review of current literature. Current Opinion in Urology. 2021; 31: 531–536.
[9]
Guan X, Guan Z, Koythong T, Liu J. Robot-assisted Transvaginal Single-site Sacrocolpopexy for Pelvic Organ Prolapse. Journal of Minimally Invasive Gynecology. 2021; 28: 1141.
[10]
Larouche M, Belzile E, Geoffrion R. Surgical Management of Symptomatic Apical Pelvic Organ Prolapse. Obstetrics & Gynecology. 2021; 137: 1061–1073.
Share
Back to top